Evidence map›Paper›PMID 32299795›Full record

ArticleAnnals of the rheumatic diseases2021

Management of rheumatic diseases in the time of covid-19 pandemic: perspectives of rheumatology practitioners from India.

Latika Gupta, Durga Prasanna Misra, Vishwesh Agarwal, Suma Balan, Vikas Agarwal

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in Annals of the rheumatic diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Survey-based observational research: Quality, relevance and optimal use in the post-COVID-19 era.The journal of the Royal College of Physicians of Edinburgh · 2022
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. COVID-19 and Myositis: What We Know So Far.Current rheumatology reports · 2021
    Review
  11. Managing patients using telerheumatology: Lessons from a pandemic.Best practice & research. Clinical rheumatology · 2021
    Review
  12. Review
  13. COVID-19: What Do Rheumatologists Need to Know?Current rheumatology reports · 2021
    Review
  14. Observational
  15. Article
  16. Reporting Survey Based Studies - a Primer for Authors.Journal of Korean medical science · 2020
    Review
  17. Review
  18. Implications of COVID-19 in pediatric rheumatology.Rheumatology international · 2020
    Review
  19. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Latika GuptaClinical Immunology and Rheumatology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, UP, India.ORCID 0000-0003-2753-2990
Durga Prasanna MisraClinical Immunology and Rheumatology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, UP, India.ORCID 0000-0002-5035-7396
Vishwesh AgarwalMahatma Gandhi Mission's Medical College, Navi Mumbai, Maharashtra, India.
Suma BalanDepartment of Paediatric Rheumatology, Amrita Institute of Medical Sciences and Research Centre, Cochin, Kerala, India.
Vikas AgarwalClinical Immunology and Rheumatology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, UP, India vikasagr@yahoo.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ArthritisCOVID-19Rheumatic DiseasesRheumatologyHumansIndiaPandemicsSARS-CoV-2antirheumatic agentsautoimmune diseasesbiological therapycommunicable diseases, importedglucocorticoids

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.